5000 ORAL Long-term Outcome of HER2-positive (HER2+)...

5000 ORAL Long-term Outcome of HER2-positive (HER2+) Metastatic Breast Cancer (MBC) Patients (pts) Achieving Durable Complete Remission (DCR) After Trastuzumab (T)-containing Chemotherapy (CT)

Gullo, G., Zuradelli, M., Kelleher, F., Sclafani, F., Donovan, N. O', Lyons, T., Masci, G., Santoro, A., Crown, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71442-3
Date:
September, 2011
File:
PDF, 57 KB
english, 2011
Conversion to is in progress
Conversion to is failed